Navigation Links
BioConvergence® Presents at BioLogistics Summit on Risk Matrix for Biosamples during Shipment

Bloomington, Indiana (PRWEB) June 19, 2013

BioConvergence team members Curtis Strother and Désirée Valentine joined the speaking faculty at 2013’s BioLogistics Summit in San Francisco earlier this month.

The conference, coordinated by Cold Chain IQ and IQPC, addressed the increasingly complex logistical issues surrounding biologics. This “complexity” is, in part, attributed to current trends of globalization, outsourcing, and personalized medicine.

“Implicit within these trends is an increase in movement, which is often associated with quality and product integrity issues,” according to Strother, Senior Technical Services Scientist & Project Manager at BioConvergence.

“To avoid these issues, it is important to design a custom transportation strategy for your biosample that will minimize risk of degradation in a cost-effective manner. During our presentation, we introduced a risk matrix for biosamples that we developed to help organizations make informed logistical decisions based on the unique attributes of their biosamples,” Strother relates.

The matrix evaluates biosamples on four parameters: storage/shipping temperature, shipping destination, type of sample, and sample stability. The risk-reduction recommendations that BioConvergence then applies to its shipments are based on best practices guiding relatable temperature-sensitive products within the pharmaceutical industry.

“More than anything, this matrix guides our organization in having a targeted discussion surrounding the risks that biosamples are exposed to and what measures we can take to achieve an acceptable level of risk-tolerance,” adds Valentine, Senior Supply Chain Manager and Business Alliance Manager at BioConvergence.

To learn more about minimizing risk to biosamples and to access the full presentation, please visit

An expanded discussion of BioConvergence’s recommended temperature-controlled shipping strategies will take place this fall during the 11th Annual Cold Chain GDP & Temperature Management Logistics Global Forum when Valentine and Associate Process Engineer, Travis Hudson, will conduct a discussion on key findings discovered through international shipment case studies.

About BioConvergence
BioConvergence is a contract service provider to the life sciences industry, offering outsourcing partnerships for formulation development, testing, production, and supply chain services. Headquartered in Bloomington, Indiana, they have over 50 employees with more than four centuries’ worth of combined experience in the pharmaceutical industry. Their unique E-Transparency® System provides transparency and flexibility to their clients, while offering superior, quality-driven outsourcing services. For more information, visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. BioConvergence® Launches New Blog Aimed at Exploring Best Practices of Pharmaceutical and Biotechnology Industries
2. BioConvergence® Celebrates Seventh Anniversary as a Life Sciences Contract Service Provider
3. SACHEM Presents ZeoGen™ Structure Directing Agents at the 17th Annual IZC in Moscow
4. AbbVie Presents Results from Phase I Study of Investigational Oncology Compound ABT-199 at American Society of Clinical Oncology Annual Meeting
5. JULABO USA Inc. Presents the New PRESTO® W91 and W92 Series of Highly Dynamic Temperature Control Systems
6. Organogenesis Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers
7. Cempra Presents Post-Phase 2 Analysis of Solithromycins Efficacy and Safety Results from Patients with Community Acquired Bacterial Pneumonia (CABP)
8. Trigemina Presents at American Pain Society 32nd Annual Scientific Meeting
9. Patheon Exhibits and Presents at the 2013 IQPC Global Formulation and Drug Delivery Summit
10. Upsher-Smith Presents Favorable Phase I Data For USL261, A Novel Formulation Of Intranasal Midazolam, At 65th Annual Meeting Of The American Academy Of Neurology
11. Assemblyman Levine Presents Resolution Recognizing Rare Disease Day at Capitol
Post Your Comments:
(Date:11/24/2015)... -- SHPG ) announced today that Jeff Poulton ... th Annual Healthcare Conference in New York City ... EST (1:30 p.m. GMT). --> SHPG ) announced today ... the Piper Jaffray 27 th Annual Healthcare Conference in ... 2015, at 8:30 a.m. EST (1:30 p.m. GMT). --> ...
(Date:11/24/2015)... Ltd. (OTCQB: TIKRF) today announced that its Annual General Meeting of Shareholders ... Israel time, at the law offices of Goldfarb Seligman ... Floor, Tel Aviv, Israel . ... to the Board of Directors; , election of Liat ... an amendment to certain terms of options granted to our Chief Executive ...
(Date:11/24/2015)... , Nov. 24, 2015  Twist Bioscience, ... that Emily Leproust, Ph.D., Twist Bioscience chief executive ... Healthcare Conference on December 1, 2015 at 3:10 ... in New York City. --> ... . Twist Bioscience is on Twitter. Sign ...
(Date:11/24/2015)... ... November 24, 2015 , ... InSphero AG, the leading ... culture models, has promoted Melanie Aregger to serve as Chief Operating Officer. ... on the management team and was promoted to Head of InSphero Diagnostics ...
Breaking Biology Technology:
(Date:11/11/2015)... Minn. , Nov. 11, 2015   MedNet Solutions ... entire spectrum of clinical research, is pleased to announce that ... in Clinical Trials (PCT) event, to be held November ... be able to view live demonstrations of iMedNet ... and learn how iMedNet has been able to ...
(Date:11/9/2015)... 9, 2015  Synaptics Inc. (NASDAQ: SYNA ), ... broader entry into the automotive market with a comprehensive ... pace of consumer electronics human interface innovation. Synaptics, industry-leading ... for the automotive industry and will be implemented in ... Europe , Japan , and ...
(Date:10/29/2015)... 29, 2015  The J. Craig Venter Institute (JCVI) ... Synthesis and Biosecurity: Lessons Learned and Options for the ... and Human Services guidance for synthetic biology providers has ... --> --> Synthetic biology ... potential to pose unique biosecurity threats. It now is ...
Breaking Biology News(10 mins):